[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100624778":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":7,"locations":13,"responsibleParty":33,"collaborators":7,"id":35,"slug":36,"hasResults":37,"nctId":38,"briefTitle":39,"officialTitle":39,"acronym":7,"eligibilityCriteria":40,"healthyVolunteers":37,"sex":41,"minAge":42,"maxAge":43,"enrollmentInfo":44,"targetDuration":7,"studyType":47,"phases":7,"briefSummary":48,"conditions":49,"keywords":7,"overallStatus":15,"whyStopped":7,"lastUpdateSubmitDate":51,"lastUpdatePostDateStruct":52,"startDateStruct":55,"completionDateStruct":57,"leadSponsor":59,"locationsCount":60},{"fullName":5,"class":6},"Ain Shams University","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DIAGNOSTIC_TEST","Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios","Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Powerful Predictors of ARDS in Pediatric Burn Patients",[14],{"facility":5,"status":15,"city":16,"state":7,"zip":7,"country":17,"countryCode":18,"cosmosGeoPoint":19,"geoPoint":24,"contacts":25},"RECRUITING","Cairo","Egypt","EG",{"type":20,"coordinates":21},"Point",[22,23],31.24967,30.06263,{"lat":23,"lon":22},[26,31],{"name":27,"role":28,"phone":29,"phoneExt":7,"email":30},"Ahmed Kamal Kamar Kamar, M.B.B.CH., M.Sc.","CONTACT","00201027733119","ahmedkamar@med.asu.edu.eg",{"name":5,"role":28,"phone":7,"phoneExt":7,"email":32},"ahmed_kamal_2amar@hotmail.com",{"type":34,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100624778","turning-ratios-into-prognosis-neutrophil-to-lymphocyte-and-platelet-to-lymphocyte-ratios-as-powerful-predictors-of-ards-in-pediatric-burn-patients-a-prospective-evaluation-100624778",false,"NCT07414056","Turning Ratios Into Prognosis: Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Powerful Predictors of ARDS in Pediatric Burn Patients: A Prospective Evaluation","Inclusion Criteria:\n\n* Age 1-12 years.\n* Patients presenting within 24 hours of burn injury.\n* Patients presenting with severe burns 20-40% of total body surface area (TBSA).\n* Thermal burns or scalds.\n* Both sexes.\n\nExclusion Criteria:\n\n* Patient refusal to participate in the trial.\n* Age \\\u003C1 \\& \\>12 years.\n* Delayed admission \\>24h post-injury.\n* Patients presenting with burns \\\u003C20% or \\>40% of TBSA.\n* Non-thermal burns.\n* Associated medical comorbidities: Chronic liver or kidney diseases, anemia.\n* Preexisting chronic lung disease (e.g., cystic fibrosis, severe bronchopulmonary dysplasia).\n* Inflammatory conditions (e.g., inflammatory bowel disease).\n* Immunocompromised individuals, autoimmune diseases, those undergoing treatment with immunosuppressants, corticosteroids, cytotoxic chemotherapy.\n* Known malignancies, hematologic malignancy or conditions altering WBC\u002Fplatelets significantly.\n* Previous malnutrition.\n* Immunosuppressive therapy prior to admission (e.g., chronic steroids).","ALL","1 Year","12 Years",{"count":45,"type":46},60,"ESTIMATED","OBSERVATIONAL","The aim of this study is to evaluate the role of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as predictors for development of ARDS in pediatric burn patients.",[50],"Acute Respiratory Distress Syndrome (ARDS)","2026-02-27",{"date":53,"type":54},"2026-03-02","ACTUAL",{"date":56,"type":54},"2025-11-10",{"date":58,"type":46},"2027-11-10",{"name":5,"class":6},1]